NEW YORK (GenomeWeb News) – Swiss proteomics firm Biognosys said this week that it has secured $1.0 million in funding in the form of a convertible loan.

The company, which specializes in targeted proteomics and mass spec-based biomarker discovery, said it will use the money to expand its commercial operations and product development.

Biognosys was spun out of Ruedi Aebersold's laboratory in 2008 at the Swiss Federal Institute of Technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.